Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Shoulder Arthroplasty Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Device
6.1 Shoulder Arthroplasty Resurfacing Implants
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Shoulder Arthroplasty Trauma Devices
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Shoulder Arthroplasty Platform Systems
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Procedure
7.1 Partial Shoulder Arthroplasty
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Total Shoulder Arthroplasty
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Revision Shoulder Arthroplasty
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Indication
8.1 Arthritis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Fracture/Dislocation
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Rotator Cuff Tear Arthropathy
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Hill Sachs Defect
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Orthopedic Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Ambulatory Surgical Centers
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast

10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast

11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Arthrex Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.2 BioTek Instruments Inc. (Agilent Technologies Inc.)
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Conmed Corporation
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 DJO Global (Colfax Corporation)
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Exactech Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Implantcast GmbH
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Integra LifeSciences Corporation
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Johnson & Johnson
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Kinamed Incorporated
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Limacorporate S.p.A.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Medacta Group
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Smith and Nephew Plc
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 Stryker Corporation
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
15.3.14 Zimmer Biomet
15.3.14.1 Company Overview
15.3.14.2 Product Portfolio
15.3.14.3 Financials
15.3.14.4 SWOT Analysis